Show
Sort by
-
- Journal Article
- A1
- open access
Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study
-
Preliminary safety and pharmacokinetics of the MET-TKI DO-2 in patients with advanced solid tumors harboring MET aberrations : a phase I study
-
- Journal Article
- A1
- open access
Improving completion rates of patient-reported outcome measures in cancer clinical trials : scoping review investigating the implications for trial designs
-
- Journal Article
- A1
- open access
Radiotherapy in cutaneous lymphomas : recommendations from the EORTC cutaneous lymphoma tumour group
-
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres : a population-based study in Belgium
-
- Journal Article
- A1
- open access
METRO-PD1 : phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors
-
- Journal Article
- A1
- open access
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023
-
- Journal Article
- A1
- open access
Defining the role of real-world data in cancer clinical research : the position of the European Organisation for Research and Treatment of Cancer
-
- Journal Article
- A1
- open access
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
-
- Journal Article
- A1
- open access
Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours